Jyothy Labs Ltd
BSE:532926
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Jyothy Labs Ltd
BSE:532926
|
IN |
|
Ayala Corp
OTC:AYYLF
|
PH |
|
Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret AS
IST:ANGEN.E
|
TR |
|
Aten International Co Ltd
TWSE:6277
|
TW |
Balance Sheet
Balance Sheet Decomposition
Jyothy Labs Ltd
Jyothy Labs Ltd
Balance Sheet
Jyothy Labs Ltd
| Mar-2009 | Mar-2010 | Mar-2011 | Mar-2012 | Mar-2013 | Mar-2014 | Mar-2015 | Mar-2016 | Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | Mar-2024 | Mar-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||
| Cash & Cash Equivalents |
1 019
|
1 223
|
1 103
|
438
|
193
|
345
|
252
|
223
|
391
|
615
|
748
|
149
|
719
|
760
|
1 057
|
844
|
772
|
|
| Cash |
217
|
302
|
262
|
407
|
152
|
309
|
252
|
180
|
353
|
575
|
701
|
93
|
719
|
760
|
1 057
|
844
|
772
|
|
| Cash Equivalents |
802
|
921
|
841
|
31
|
41
|
36
|
0
|
43
|
38
|
40
|
47
|
56
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
603
|
2 007
|
886
|
299
|
1 617
|
1 244
|
114
|
1 198
|
1 335
|
1 721
|
5 255
|
6 709
|
|
| Total Receivables |
606
|
991
|
1 180
|
1 121
|
973
|
850
|
718
|
1 018
|
1 331
|
2 004
|
1 975
|
1 709
|
1 320
|
1 842
|
1 633
|
2 257
|
3 043
|
|
| Accounts Receivables |
429
|
707
|
1 054
|
809
|
804
|
668
|
574
|
941
|
1 171
|
1 607
|
1 534
|
1 224
|
943
|
1 431
|
1 378
|
2 014
|
2 744
|
|
| Other Receivables |
177
|
284
|
126
|
312
|
169
|
182
|
144
|
77
|
160
|
397
|
441
|
485
|
377
|
411
|
255
|
243
|
299
|
|
| Inventory |
470
|
790
|
827
|
1 457
|
2 014
|
2 012
|
2 032
|
2 009
|
2 102
|
2 038
|
2 140
|
2 396
|
2 907
|
3 109
|
3 143
|
2 872
|
3 414
|
|
| Other Current Assets |
44
|
12
|
1 709
|
272
|
314
|
368
|
494
|
424
|
688
|
353
|
111
|
119
|
104
|
195
|
198
|
164
|
176
|
|
| Total Current Assets |
2 140
|
3 016
|
4 820
|
3 288
|
3 493
|
4 179
|
5 503
|
4 561
|
4 811
|
6 628
|
6 218
|
4 487
|
6 248
|
7 241
|
7 751
|
11 392
|
14 114
|
|
| PP&E Net |
2 025
|
2 377
|
2 383
|
3 241
|
3 069
|
3 075
|
2 999
|
2 835
|
3 145
|
3 131
|
3 224
|
3 814
|
3 658
|
3 392
|
3 394
|
3 469
|
3 712
|
|
| PP&E Gross |
2 025
|
2 377
|
2 383
|
3 241
|
3 069
|
3 075
|
2 999
|
2 835
|
3 145
|
3 131
|
3 224
|
3 814
|
3 658
|
3 392
|
3 394
|
3 469
|
3 712
|
|
| Accumulated Depreciation |
445
|
594
|
643
|
1 320
|
1 641
|
1 856
|
0
|
270
|
550
|
824
|
999
|
1 506
|
2 022
|
2 467
|
2 879
|
3 162
|
3 608
|
|
| Intangible Assets |
46
|
0
|
89
|
75
|
60
|
45
|
40
|
59
|
50
|
66
|
62
|
59
|
47
|
39
|
61
|
55
|
63
|
|
| Goodwill |
43
|
0
|
44
|
7 018
|
7 568
|
7 863
|
7 863
|
7 863
|
7 863
|
7 863
|
7 863
|
7 863
|
7 863
|
7 863
|
7 863
|
7 863
|
7 863
|
|
| Note Receivable |
0
|
0
|
350
|
538
|
872
|
686
|
1 752
|
2 355
|
1 445
|
1 144
|
172
|
258
|
227
|
270
|
594
|
521
|
758
|
|
| Long-Term Investments |
2
|
0
|
622
|
15
|
15
|
15
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
52
|
0
|
13
|
19
|
104
|
672
|
174
|
23
|
1 217
|
957
|
1 883
|
1 879
|
1 516
|
1 422
|
954
|
711
|
398
|
|
| Other Assets |
43
|
0
|
44
|
7 018
|
7 568
|
7 863
|
7 863
|
7 863
|
7 863
|
7 863
|
7 863
|
7 863
|
7 863
|
7 863
|
7 863
|
7 863
|
7 863
|
|
| Total Assets |
4 308
N/A
|
5 394
+25%
|
8 320
+54%
|
14 193
+71%
|
15 181
+7%
|
16 535
+9%
|
18 331
+11%
|
17 696
-3%
|
18 531
+5%
|
19 790
+7%
|
19 423
-2%
|
18 362
-5%
|
19 560
+7%
|
20 228
+3%
|
20 617
+2%
|
24 009
+16%
|
26 908
+12%
|
|
| Liabilities | ||||||||||||||||||
| Accounts Payable |
107
|
304
|
231
|
729
|
719
|
622
|
819
|
1 041
|
1 492
|
1 511
|
1 790
|
1 308
|
1 923
|
2 366
|
2 143
|
2 761
|
2 903
|
|
| Accrued Liabilities |
0
|
319
|
188
|
818
|
570
|
538
|
563
|
1 762
|
190
|
64
|
319
|
300
|
224
|
249
|
281
|
312
|
345
|
|
| Short-Term Debt |
0
|
0
|
583
|
1 237
|
1 268
|
0
|
0
|
0
|
492
|
2 768
|
2 154
|
2 209
|
1 169
|
1 265
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
30
|
44
|
741
|
68
|
1 204
|
4 436
|
4 436
|
2 636
|
618
|
810
|
204
|
202
|
185
|
247
|
248
|
|
| Other Current Liabilities |
569
|
581
|
641
|
525
|
1 069
|
1 091
|
651
|
810
|
813
|
1 130
|
981
|
818
|
1 207
|
1 125
|
1 454
|
1 486
|
1 612
|
|
| Total Current Liabilities |
676
|
1 203
|
1 673
|
3 352
|
4 368
|
2 318
|
3 236
|
8 048
|
7 423
|
8 108
|
5 861
|
5 446
|
4 727
|
5 207
|
4 063
|
4 805
|
5 108
|
|
| Long-Term Debt |
5
|
130
|
77
|
4 379
|
4 268
|
5 268
|
4 490
|
73
|
55
|
38
|
20
|
335
|
292
|
245
|
280
|
259
|
365
|
|
| Deferred Income Tax |
156
|
133
|
163
|
161
|
9
|
11
|
0
|
409
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Minority Interest |
3
|
5
|
5
|
67
|
49
|
16
|
14
|
27
|
67
|
139
|
215
|
291
|
378
|
407
|
21
|
19
|
0
|
|
| Other Liabilities |
0
|
45
|
91
|
110
|
102
|
1 577
|
767
|
178
|
230
|
341
|
491
|
585
|
634
|
746
|
763
|
843
|
940
|
|
| Total Liabilities |
839
N/A
|
1 516
+81%
|
2 009
+33%
|
8 069
+302%
|
8 796
+9%
|
9 191
+4%
|
8 508
-7%
|
8 681
+2%
|
7 641
-12%
|
8 347
+9%
|
6 158
-26%
|
6 076
-1%
|
5 274
-13%
|
5 792
+10%
|
5 127
-11%
|
5 926
+16%
|
6 413
+8%
|
|
| Equity | ||||||||||||||||||
| Common Stock |
73
|
73
|
81
|
81
|
161
|
181
|
181
|
181
|
182
|
182
|
367
|
367
|
367
|
367
|
367
|
367
|
367
|
|
| Retained Earnings |
2 324
|
2 729
|
2 948
|
3 154
|
2 865
|
3 233
|
4 606
|
3 634
|
5 485
|
6 040
|
7 857
|
6 874
|
8 875
|
9 022
|
10 087
|
12 681
|
15 085
|
|
| Additional Paid In Capital |
1 065
|
1 065
|
3 272
|
2 879
|
2 796
|
3 919
|
4 767
|
4 786
|
4 884
|
4 903
|
5 041
|
5 041
|
5 041
|
5 041
|
5 041
|
5 041
|
5 043
|
|
| Other Equity |
7
|
11
|
11
|
11
|
563
|
11
|
269
|
414
|
339
|
318
|
1
|
4
|
3
|
6
|
5
|
6
|
0
|
|
| Total Equity |
3 469
N/A
|
3 878
+12%
|
6 311
+63%
|
6 124
-3%
|
6 386
+4%
|
7 344
+15%
|
9 824
+34%
|
9 015
-8%
|
10 890
+21%
|
11 442
+5%
|
13 265
+16%
|
12 286
-7%
|
14 286
+16%
|
14 436
+1%
|
15 490
+7%
|
18 083
+17%
|
20 495
+13%
|
|
| Total Liabilities & Equity |
4 308
N/A
|
5 394
+25%
|
8 320
+54%
|
14 193
+71%
|
15 181
+7%
|
16 535
+9%
|
18 331
+11%
|
17 696
-3%
|
18 531
+5%
|
19 790
+7%
|
19 423
-2%
|
18 362
-5%
|
19 560
+7%
|
20 228
+3%
|
20 617
+2%
|
24 009
+16%
|
26 908
+12%
|
|
| Shares Outstanding | ||||||||||||||||||
| Common Shares Outstanding |
290
|
290
|
323
|
323
|
323
|
362
|
362
|
362
|
363
|
364
|
367
|
367
|
367
|
367
|
367
|
367
|
367
|
|